Stay updated with breaking news from Assisted Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
From the desk of Nick Kadysh, Founding CEO, PharmAla Biotech Over the past 48 hours, a large number of shareholders have reached out to me for my thoughts on the recent FDA...
From the prospect of semaglutide and MDMA for substance use disorder to evolving research around personality disorders and OCD, here are 5 key topics from the annual psychiatric meeting.
Lykos Therapeutics' new drug application for MDMA plus psychiatric intervention for adults with PTSD will be the first reviewed by an FDA committee for such a therapy.
In an interview, Paul Appelbaum, MD, discussed issues clinicians will need to bring up to their patients if the FDA approves a psychedelic-assisted therapy.
If you are interested in learning how to start a business in the pet industry, here are 33 pet business ideas to get you inspired and started